NR4A1 and neoplasm: In our analysis, the highest absolute differences between observed and predicted OS were observed for patients with hormone-receptor negative disease, larger tumor size, and high number of nodes (≥4 positive lymph nodes), namely those patients traditionally considered at higher risk of relapse.